Mrs. Kimberly Denise Rath is a pharmacist who is specialized in Pharmacotherapy in Chesapeake, Virginia. Patients can reach her at 3536 Riverwood Cres, Chesapeake or contact her on 757-204-4343. Active license number of Mrs. Kimberly Denise Rath is 0202205776 for Pharmacotherapy in Virginia. Mrs. Kimberly Denise Rath is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Mrs. Kimberly Denise Rath speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mrs. Kimberly Denise Rath are as mentioned below.
NPI Number:
1407841141
NPI Enumeration Date:
19 Sep, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Kimberly Denise Rath are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
0202205776
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3536 Riverwood Cres, Chesapeake, Virginia
Zip:
23322-2849
Phone Number:
757-204-4343
Fax Number:
757-282-5980
Patients can reach Mrs. Kimberly Denise Rath at 3536 Riverwood Cres, Chesapeake, Virginia or can call on phone at 757-204-4343.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.